Arthneeti

Colgate-Palmolive (India) Q2 FY27 Share Price & Earnings Call Analysis

₹1,596.50-2.04% today
Market cap
₹43,420 Cr
P/E
31.72
ROE
82.73%
PEG
3.78
Price to sales
7.00
Debt to equity
0.03
52W high / low
₹2,295 / ₹1,596
Sales growth (5Y)
4.51%
EBITDA margin
30.62%
Net profit margin
22.27%
Promoter holding
51.00%
Sales (last year)
₹6,204 Cr

Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.[1]

Guidance scorecard · Q2 FY27 call

What Colgate-Palmolive (India) Ltd's management guided
and where it ranks in Personal Products

#7of 7 in
Personal Products
Revenue10–20%MarginsDown 0–2%CapexPlannedFundraisingWhat management saidOrder bookWhat management said

RevenueQ1 FY27 call

10–20%
  • Colgate-Palmolive India expects continued good growth, balancing price, volume, and premium mix rather than relying solely on pricing.
  • Premium segment is a key growth driver, growing 6 times faster than the market; significant opportunity remains as only 19% of toothpaste is currently premium priced (above 140 index) vs. a potential 40-60%.
  • E-commerce and quick commerce are expanding premium product discovery and penetration, supporting higher margin growth.
  • Growth in rural penetration (e.g., increase in daily brushing) and urban city-to-city corridor expansion also support volume growth.

2 more points from Colgate-Palmolive (India) Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Down 0–2%

See what Colgate-Palmolive (India) Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Sensodyne is planning a significant capex of ₹2,000 crore, signaling a strong investment in the premium whitening toothpaste category.
  • The company is focused on premiumisation, channel expansion including e-commerce and D2C, and investing heavily in advertising and promotions to drive growth.
  • Colgate-Palmolive is also investing in advertising at a high level (~16% of sales), with over 50-60% advertising investment geared towards premium products to fuel growth.
  • Sustained investment is evident in ongoing consumer outreach programs (e.g., Bright Smiles Bright Future) which are ring-fenced and growing yearly to improve oral health awareness.
Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Colgate-Palmolive (India) Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

Ask what Colgate-Palmolive (India) Ltd said on the order book →

Full Q1 FY27 analysis
Full Personal Products ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Personal Products
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Honasa Consumer LtdGood growth
    3
See all potential multibaggersWhere does Colgate-Palmolive (India) Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Personal Products companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹2,041 Cr61.0
240%+Flat₹400 Cr35.6
3Honasa Consumer Ltd20–40%Up 0–2%₹14,745 Cr58.4
410–20%Flat₹87,493 Cr42.1
510–20%Flat₹68,298 Cr34.4
610–20%Flat₹16,419 Cr21.7

Sign up free to see every company in the sector ranking and track Colgate-Palmolive (India) Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Personal Products ranking

Financials of Colgate-Palmolive (India) Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Colgate-Palmolive (India) Ltd

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%
FIIs +24.62%24.51%24.44%24.94%23.72%22.23%20.39%17.16%15.18%13.60%13.60%13.71%
DIIs +5.60%5.82%5.72%5.55%6.57%7.84%9.34%11.95%13.50%15.25%15.54%15.45%
Government +0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.00%
Public +18.50%18.38%18.54%18.22%18.44%18.65%19.00%19.59%20.03%19.87%19.57%19.82%
No. of Shareholders2,38,2002,31,0612,48,8012,39,1932,65,3372,82,9733,05,2223,32,4093,37,6083,33,7413,26,8173,29,953

Financials of Colgate-Palmolive (India) Ltd

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +1,4711,3961,4901,4971,6191,4621,4631,4341,5201,4861,5951,6031,706
Expenses +9899279589881,1221,0079649811,0541,0441,0861,1201,232
Operating Profit482468532508497454498453465442510483473
OPM %33%34%36%34%31%31%34%32%31%30%32%30%28%
Other Income +2118232376201918153101922
Interest1211111111111
Depreciation44414242424138383736353934
Profit before tax458443511489530433478432442436474462460
Tax %26%26%26%26%26%25%26%26%26%26%25%26%26%
Net Profit +340330380364395323355321328324353343342
EPS in Rs12.5012.1413.9613.3814.5211.8713.0511.7912.0411.9112.9912.6112.56

Financials of Colgate-Palmolive (India) Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +3,9823,8683,9824,1884,4624,5254,8415,1005,2265,6806,0406,0356,391
Expenses +3,1592,9293,0383,0743,2263,3233,3313,5343,6793,7794,0824,1654,482
Operating Profit8239409441,1141,2361,2021,5101,5661,5471,9011,9581,8701,908
OPM %21%24%24%27%28%27%31%31%30%33%32%31%30%
Other Income +32741266849302642571396472
Interest00002107655444
Depreciation75111133157159198182177175172163146145
Profit before tax7808358519831,1431,0431,3501,4091,4101,7811,9301,7841,832
Tax %28%30%32%32%32%22%23%23%26%26%26%26%
Net Profit +5595815776737768161,0351,0781,0471,3241,4371,3251,362
EPS in Rs20.5521.3721.2324.7628.5230.0238.0739.6538.5048.6752.8348.7350.07
Dividend Payout %58%47%47%97%81%93%100%101%101%119%97%119%

Financials of Colgate-Palmolive (India) Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital14272727272727272727272727
Reserves7571,0041,2471,4971,4201,5671,1391,7071,6891,8471,6371,5571,590
Borrowings +00008310291836972614749
Other Liabilities +9329721,0371,0391,0979081,6371,0841,0981,2501,2931,7771,971
Total Liabilities1,7022,0032,3112,5642,6262,6042,8942,9022,8833,1973,0193,4083,638
Fixed Assets +7821,0081,1081,1461,1911,1231,065963862794776718673
CWIP14178167159199190145122114110382752
Investments37313131311919000000
Other Assets +7428851,0051,2281,2061,2721,6661,8171,9072,2922,2042,6632,913
Total Assets1,7022,0032,3112,5642,6262,6042,8942,9022,8833,1973,0193,4083,638

Financials of Colgate-Palmolive (India) Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +6386896886949839307841,6261,1761,1991,3941,806
Cash from Investing Activity +-272-237-342-207-96-1971-108-87956374
Cash from Financing Activity +-385-391-341-380-815-891-956-1,091-1,087-1,195-1,671-1,422
Net Cash Flow-186151077320-1014278283-221758
Free Cash Flow3394173674858798697271,5761,1071,1231,3231,730
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit103%100%105%93%113%104%76%127%101%88%100%121%

Financials of Colgate-Palmolive (India) Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6101218171191611111413
Inventory Days637272565869797868637675
Days Payable128136148152144142179169155187185275
Cash Conversion Cycle-59-55-63-79-68-63-91-75-76-113-95-188
Working Capital Days-40-43-39-33-36-23-84-25-32-46-37-59
ROCE %114%96%74%71%73%65%92%92%79%97%105%108%

Guidance history

How Colgate-Palmolive (India) Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →10–20%Down 0–2%Planned——
Q4 FY25 call →0–10%Flat———

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

10out of 100

Momentum score · price trend

10 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−29.2%25%
Last 6 months−23.8%15%
Last 3 months−23.1%14%

The price is 57.7% below its all-time high of ₹3,774.9 (27 Sept 2024). Stocks more than 20% below their peak have their score halved, so 19 became 10.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Colgate-Palmolive (India) Ltd: 0.4 × 25 + 0.4 × 15 + 0.2 × 14 = 19, halved to 10 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Colgate-Palmolive (India) Ltd's management said in earlier quarters

Others in Personal Products this season

  • Aakaar Medical (Q2 FY27)

    Revenue from operations in H1 FY27: INR 43.72 Cr, up 72.6% YoY from INR 25.32 Cr in H1 FY26 (Page 12, 11, 4) . Key investor presentation takeaways from Aakaar M

  • Recode Studios Ltd (Q4 FY26)

    The company plans to sustain marketing spends at about 20% of revenue to support growth and brand visibility, implying continued focus on operating profits…

  • Godrej Consumer Products Ltd (Q2 FY27)

    Consolidated net sales for Q2 FY2027: ₹4,396 crore, up 19% year-on-year; constant currency growth 15% (Page 8) . Key investor presentation takeaways from Godrej

  • Anondita Medicare Ltd (Q3 FY26)

    Revenue from operations (Standalone) for H1 FY26: ₹4,765.06 lakh; H1 FY25: ₹2,497.06 lakh; YoY growth: 91% (Page 26) . Key investor presentation takeaways from

Compare:vs Godrej Consumer Products Ltdvs Dabur India Ltdvs Cupid Ltd